-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Zymeworks, Raises Price Target to $40

Benzinga·08/07/2026 14:01:22
Listen to the news
Wells Fargo analyst Eva Fortea Verdejo maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $37 to $40.